{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T05:51:05Z","timestamp":1774763465311,"version":"3.50.1"},"reference-count":23,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,2]]},"DOI":"10.18632\/oncotarget.15369","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:33:37Z","timestamp":1487781217000},"page":"29906-29913","source":"Crossref","is-referenced-by-count":23,"title":["Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy"],"prefix":"10.18632","volume":"8","author":[{"given":"Simona","family":"Luatti","sequence":"first","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Baldazzi","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Marzocchi","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Ameli","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Bochicchio","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Soverini","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Castagnetti","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Tiribelli","sequence":"additional","affiliation":[{"name":"Division of Hematology and Bone Marrow Transplantation, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Gugliotta","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Baccarani","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Cavo","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianantonio","family":"Rosti","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Testoni","sequence":"additional","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. and A. Ser\u00e0gnoli\u201d, University of Bologna, \u201cS Orsola-Malpighi\u201d University Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and GIEMSA staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.seminhematol.2006.12.001","article-title":"Introduction: chronic myelogenous leukemia (CML)","volume":"44","author":"Kantarjian","year":"2007","journal-title":"Semin Hematol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Cortes","year":"2009","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/gcc.2870080406","article-title":"Translocation of BCR to chromosme 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia","volume":"8","author":"Grosveld","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cancergencyto.2004.02.026","article-title":"Fluorescence in situ hybridization characterization of different cryptic BCR\/ABL rearrangements in chronic myeloid leukemia","volume":"155","author":"Cuthbert","year":"2004","journal-title":"Cancer Genet and Cytogenet"},{"key":"6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0145-2126(00)00034-5","article-title":"Clinical significance of reverse BCR\/ABL gene rearrangement in Ph-negative chronic myelogenous leukemia","volume":"24","author":"Chandra","year":"2000","journal-title":"Leukemia Research"},{"key":"7","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1080\/1042819021000003063","article-title":"Location of the BCR\/ABL fusion genes on both chromosomes 9q34 in Ph negative Chronic Myeloid Leukemia","volume":"43","author":"Pol\u00e1k","year":"2002","journal-title":"Leukemia and Lymphoma"},{"key":"8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-4608(02)00662-3","article-title":"Chimeric BCR\/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia","volume":"141","author":"Campo","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cancergencyto.2005.05.010","article-title":"Masked Philadelphia chromosome due to atypical BCR\/ABL location in the 9q34 band and duplication on the der(9) in a case of chronic myelogenous leukemia","volume":"163","author":"Sessarego","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"issue":"30","key":"10","first-page":"241","article-title":"Location of the BCR\/ABL fusion genes on both chromosomes 9 and 22 in Ph negative young CML patients: an Indian experience","volume":"2014","author":"Patel","journal-title":"Indian J Hematol and Blood Transfus"},{"key":"11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cancergencyto.2005.04.021","article-title":"BCR\/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present","volume":"163","author":"Griffin","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00432-011-1002-4","article-title":"Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients","volume":"137","author":"Sennana","year":"2011","journal-title":"J Cancer Res and Clin Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.47102\/annals-acadmedsg.V34N9p533","article-title":"The incidence and patterns of BCR\/ABL rearrangements in chronic myeloid leukaemia (CML) using fluorescence in situ hybridization (FISH)","volume":"34","author":"Lim","year":"2005","journal-title":"Ann Acad Med Singapore"},{"key":"14","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","article-title":"Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV","volume":"118","author":"Schwaab","year":"2011","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2011-10-384651","article-title":"Additonal chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML Analysis","volume":"120","author":"Grimoldi","year":"2012","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1200\/JCO.2009.26.7963","article-title":"Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis","volume":"28","author":"Amabile","year":"2010","journal-title":"J of Clin Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cancergencyto.2008.01.007","article-title":"Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements","volume":"182","author":"Reid","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"18","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1182\/blood-2011-01-328294","article-title":"Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA WP on CML analysis","volume":"117","author":"Montaldi","year":"2011","journal-title":"Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recomandation for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Kantarjian","year":"2013","journal-title":"Blood"},{"key":"20","article-title":"Molecular Response with Nilotinib in patients with Philadelphia Negative (Ph-) Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENEST1st Sub-Analysis","author":"Rosti","year":"2015","journal-title":"ASH Meeting"},{"key":"21","article-title":"ISCN : An International System for Human Cytogenetic Nomenclature","author":"Schmid","year":"2013","journal-title":"S Karger, Basel"},{"key":"22","first-page":"4439","article-title":"Chronic Myeloid Leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA WP","volume":"114","author":"Grimoldi","year":"2009","journal-title":"Blood"},{"key":"23","first-page":"2172","article-title":"Standardized definitions of molecular response in chronic myeloid leukemia","volume":"26","author":"Hochhaus","year":"2002","journal-title":"Leukemia"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T15:47:09Z","timestamp":1750002429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":23,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,5,2]]}},"alternative-id":["15369","28404889"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15369","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}